A Mechanistic substudy of the effects of crizanlizumab and dapagliflozin on thrombosis and inflammation in COVID-19 Grant

Overview

date/time interval

January 1, 2022 - June 30, 2023

awarded by

Commonwealth Fund

administered by

Medicine-Infectious Diseases

sponsor award ID

1 OT2 HL156812-01

Affiliation

contributor

McCarthy, Matthew William Principal Investigator (Subaward) 2022 - 2023